Dw. Seol et al., Transcriptional activation of the Hepatocyte Growth Factor receptor (c-met) gene by its ligand (Hepatocyte Growth Factor) is mediated through AP-1, ONCOGENE, 19(9), 2000, pp. 1132-1137
Hepatocyte Growth Factor (HGF) exerts its biological effects via binding an
d activating a transmembrane protein tyrosine kinase receptor known as c-Me
t. Previous studies from our laboratory demonstrated that c-met gene expres
sion is inducible by its own ligand (HGF), However, the molecular mechanism
(s) involved in this process are unknown. The present study,vas carried out
to address this question. Transfection of various c-met-CAT promoter const
ructs into the mouse hepatocellular carcinoma cell line Hepa 1-6 in combina
tion with electrophoretic mobility shift assays (EMSA) identified the respo
nsive element as an activated protein-1 (AP-1) binding site (TGAGTCA) withi
n the c-mct core promoter region at position -158 to -152. The c-met AP-I e
lement binds specifically to AP-I protein as, verified by supershift assays
. EMSA studies and mutational analyses of the promoter region also revealed
that the members of the Sp family of transcription factors (Sp-1 and Sp-3)
bind to the c-met Sp-1 element (located at position -124) which is adjacen
t to the AP-1 site. We show that Sp binding dampens binding of AP-1 to its
cognate site in the c-met promoter region. Stimulation of Hepa 1-6 cells wi
th HGF resulted in a rapid and dramatic enhancement of the AP-1 binding act
ivity as well as an overall increase in the le,el of AP-I protein. Cotransf
ection of AP-1 expression vectors (c-Fos plus c-Jun) with c-met promoter co
nstructs resulted in stimulation of c-met promoter activity. We found that
transactivation of the c-met promoter by AP-1 can be blocked by Curcumin, a
n inhibitor of AP-I, Moreover, we found that the induction of the endogenou
s c-met gene by HGF is inhibited by the addition of Curcumin, The results d
emonstrate that the HGF-induced transcription of the c-met gene by HGF is,
at least in part, due to activation of the AP-1 pathway.